03 Blood

Heparin

Warfarin

Antiplatelet

Adhesion to endothelium:

Secretion:

Aggregation:

Thrombolytics

End pathway affected, thus:

Dyslipidemia

Statins

Statins act through competitive inhibition of HMG-CoA reductase, preventing conversion of HMG-CoA to mevalonic acid (the rate-limiting step in cholesterol biosynthesis). Decreased liver cholesterol synthesis leads to increased hepatic clearance of LDL from the circulation by LDL receptors. After mediating endocytosis of LDL particles, the LDL receptors are returned to the cell surface for reuse (receptor recycling); LDL is digested and used for metabolic purposes. This increase in LDL receptor recycling allows intrahepatic cholesterol levels to remain at normal levels while blood levels are kept low.

Cholestyramine

Fibrates

Niacin

Fish Oil

Anti-inflammatory

NSAIDS

kidney:

GI:

Bone:

Gout

Backlinks